Burning Rock Biotech Limited

Healthcare · Diagnostics & Research · China

Last price 10.9 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 114.96M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Burning Rock Biotech Limited develops and sells cancer therapy selection tests in the People's Republic of China and the United States. It operates in three segments: Central Laboratory Business, In-Hospital Business, and Pharma Research and Development Services. The company offers next-generation sequencing (NGS)-based tissue, liquid biopsy cancer therapy selection, and prognosis prediction tests for various cancer types, including lung cancer, gastrointestinal cancer, prostate cancer, breast cancer, lymphomas, thyroid cancer, colorectal cance...